Synbal Joins BioLabs San Diego with a Fast-Track SBIR Grant from the NCI
SAN DIEGO, Calif., November 26, 2018—Synbal, Inc., a biotechnology company developing non-viral, cell-based gene therapy candidates for rare diseases, cancer, autoimmune and degenerative [...]